available in the market, and the standard technique for a self-test involves sampling the capillary blood from the finger by a disposable lancet so that the requisite amount of blood required by the device can be obtained. Although the fingertip possesses well-developed capillaries to provide enough blood for the test, pain receptors concentrated on the fingertip induce significant pain when the skin is punctured [9] . As a result, some patients avoid the selftest, which could lead to failure of glucose control. In a survey by Park et al. [10] , 55% of the diabetes patients responded to the survey questions, and only 35% performed the self-test. These survey results show that only 20% of the patients may perform the routine self-test to control their blood glucose levels.
Despite the fact that BGT using skin puncture is a wellestablished technique [11] , the pain during sampling not only makes the patient avoid the self-test, but also causes both physiological and psychological problems, particularly in infants [12, 13] . To minimize pain, new techniques involving sampling at alternative sites with fewer pain receptors, such as the forearm, have been developed [14] .
We have recently developed a vacuum-assisted auto-lancing technique to facilitate nearly painless blood sampling [15] . The BGT results obtained for the forearm showed no significant differences to those for the finger in 50 nonfasting subjects [16] . However, a large-scale clinical study encompassing a wide range of glucose levels should precede the introduction of this new capillary blood sampling technique into clinical practice. Therefore, in the present study involving more than 500 subjects, BGT was first performed at the finger, which was immediately followed by BGT at the forearm, and then, within an hour, at the vein, and the results obtained from the 3 sites were compared to demonstrate the validity of the forearm bloodsampling technique.
MATERIALS AND METHODS

Subjects
The purpose and procedure of the study were explained to the subjects who visited the Health Enhancement Center of the Chungbuk National University Hospital for regular monitoring of fasting glucose levels. Informed consent was obtained from 530 subjects who participated in the study. The study design was approved by the institutional review board (IRB). Among the 530 subjects, only 36 (6.8%) had been previously diagnosed with diabetes. An additional 25 patients with diabetes were recruited and scheduled for regular morning visits under fasting conditions. Therefore, 494 normal subjects and 61 diabetes patients were included in the study, thereby making the total number of participants 555.
Devices
Blood samples were obtained from the finger and forearm using a disposable auto-lancet (Autolet; Geosang Med. Co., Chungju, Korea) and a vacuum-assisted autolancing device (CareLance; CKInt. Co., Cheongju, Korea), respectively. Venous blood was sampled from the antecubital vein using a vacutainer needle. Glucose concentration in the blood was measured using a portable glucometer (CareSens; i-sens Co., Ltd., Seoul, Korea), which has been certified for use in Europe (EC-Certificate, No. V1 09 04 51072 013) and also allowed for sale in the United
States by Food and Drug Administration (No. k080923).
Venous glucose levels were measured using an automated chemical analyzer (747; Hitachi, Tokyo, Japan) using hexokinase (Climate GLU; DAIICHI, Tokyo, Japan), which is currently being used for patient samples in the Clinical Laboratory of the Chungbuk National University Hospital. Both glucose-measuring devices are known to have a good performance, and are widely available in the international market. In particular, the portable glucometer is capable of measuring glucose levels in less than 5 sec by using a very small amount of capillary blood (less than 1 mL). Its accuracy and precision has been previously studied in comparison with 4 other latest device models (AccuCheck Go and Accu-Check Advantage manufactured by Roche; Optimum, Abbott; and GlucoMan PC, Menarini), which confirmed its precision and accuracy with a mini-mum bias level of <5% [17] .
Procedure
The general data about the physical characteristics of the subjects along with their medical history were recorded, followed by measurement of their height and weight to evaluate obesity. Capillary blood was sampled from the index finger of the subjects for glucose measurement (GF).
Immediately after measuring the GF value, the frontal side of the forearm was rubbed by hand for 5 sec to enhance the capillary circulation underneath before collecting the blood sample for glucose measurement (GA). After completing the BGT at the finger and forearm, the subject was moved to the Clinical Laboratory, and glucose concentration in the venous serum (GV) was measured within an hour. Therefore, GA and GF measurements were considered to be ' 'almost' ' simultaneous, while GV was measured 30-60 min after GA. Forty-one of the 555 subjects refused to undergo venous sampling; therefore, GV data were available for only 514 subjects.
Data analysis
1) Simple linear regression analysis
Since the number of the normal subjects (494) was much larger than that of patients with diabetes (61), the subjects were divided into normal and patient groups. The grouping also helped to evaluate any potential intergroup differences with regard to glucose measurement. Since our major interest was to compare GA with GF and since GF is a standard for glucose self-testing, simple linear regression analysis was performed using the SPSS/Win10.0 program by considering GF to be an independent variable. Although, GV measurement was performed 30-60 min after GA measurement, GA-GV regression analysis was performed under the reasonable assumption that blood glucose levels would not change significantly within an hour in overnight-fasted subjects (subjects fasted since the last supper of the previous day). In GA-GV regression analysis, GV was considered to be an independent variable, since, under clinical settings recommended by the WHO, the concentration of glucose in the plasma is considered to be the international standard [18] . In GA-GF and GA-GV regression analyses, slope, constant (or intercept), and
Pearson correlation coefficient were evaluated and compared between normal and patient groups.
2) Intraclass correlation analysis
The WHO considers GF and GV as the standards for self and clinical tests, respectively [18] . Therefore, the Food and Drug Administration (FDA) of the US requires a simple linear regression analysis to be performed when evaluating a new glucose measurement technique for approval [19] . However, significant measurement error and/or environmental effect might interfere with the standard measurement technique to such a degree that the standard measurement cannot be considered independent. To test this possibility, the intraclass correlation analysis was performed to evaluate the extent of agreement between the forearm BGT data and the fingertip or the vein BGT data in the measurement of glucose concentration [20] . The intraclass correlation coefficients were obtained for both GA-GF and GA-GV data sets in the normal and the patient groups.
3) Passing-Bablok regression analysis
In the above analyses, both the Pearson and intraclass correlation coefficients were comparable in value and were statistically significant (see the RESULTS section). Moreover, since no significant intergroup differences were observed, Passing and Bablok regression analysis was performed by pooling all data together [21] . This regression analysis technique allows for non-uniform distribution, such as the one in our data where having more normal subjects than the diabetic patients was of major concern. With no special assumptions in the regression procedure, 95% confidence intervals for the slope and constant parameters could be obtained in a linear relationship, which helped demonstrate the valid glucose measurement range of the forearm BGT technique.
RESULTS
Subject characteristics
The general characteristics of the subjects are summarized in Table 1 . Two hundred and two (36.4%) male and 353 (63.6%) female subjects were enrolled in the study.
Approximately 92% of the subjects were over the age of 40 yr, which is an age category with high risk of diabetes.
About 50% of the subjects were obese, and 23.4% had a history of diabetes and/or hypertension. A total of 555 subjects were divided into 2 groups: normal subjects (N= 494) and patients with diabetes (N=61).
Overall data features
Intergroup GA-GF and GA-GV difference were calculated ( Table 2 ). All mean differences were within ±10 mg/ dL, but paired student' s t test showed statistically significant differences between all comparisons (P<0.001), which can be attributed to the large sample size with relatively small variance (described in the Discussion section). The mean relative errors (or bias) were also calculated to be within ±5-12%, which were well below the error limit of ±20% recommended by CLSI and ISO [22, 23] .
The glucose levels of most subjects in the normal group ranged between 60-130 mg/dL, with a few patients, possibly those with diabetes, showing glucose levels of up to 200 mg/dL. However, these subjects were included in the normal group because the subjects in question had not been officially diagnosed with diabetes at the time of the study. At the end of the testing period, they were informed of them being at a high risk for diabetes and were recommended to visit a physician. The glucose levels in the patient group showed a very wide range (approximately 60-350 mg/dL), despite the small sample size, which was expected due to their decreased ability to regulate glucose levels even under fasting conditions.
Results of the correlation analysis
1) Results of simple linear regression analysis
The results of simple linear regression analysis of GA-GF plotted with both regression and identity lines for both groups have been shown in Fig. 1 . GA-GV regression anal- Table 1 . General characteristics of the subjects eAF and eAV represent the differences between the forearm and the finger measurements (GA-GF) and between the forearm and the vein measurements (GA-GV), respectively, and %eAF and %eAV are the corresponding bias relative to GF and GV, respectively. Table 2 . Mean (SD) values of the differences in glucose measurements in the normal and the patient groups The parameter values are summarized in Table 3 . dL, which is the clinically acceptable limit recommended by FDA [19] for the hypoglycemic region in the error grid analysis [24] . Therefore, the regression lines of GA-GF data were very close to the identity line in both groups. The GA-GV relationship also showed similar features in both groups, except for the small constant value of b=1.67 mg/ dL in the patient group.
Since there were no significant intergroup differences, all data were pooled before analysis; the results are presented in Table 3 . In GA-GF analysis, all parameter values of the pooled data were in the range of the values obtained for the individual groups. However, the slope parameter of a=0.88 in GA-GV regression analysis of pooled data was lower than the individual values obtained for both groups.
We noted that the constant value of the patient group in than that of the normal group. Considering this and knowing that the range of glucose levels in the patient group was much wider and higher than that of the normal group, we inferred that the slope value for the pooled data was smaller than the individual slope values for both groups.
The fact that the constant value of the pooled data (15.98 mg/dL) was higher than the individual values obtained for both normal (b=13.29 mg/dL) and patient (b=1.67 mg/ dL) groups also supports this statistical outcome.
2) Intraclass correlation coefficients
The intraclass correlation coefficient values were slightly smaller than the Pearson correlation coefficients by magnitudes of 0.01-0.14 ( Table 3) . Furthermore, the intraclass correlation coefficient values were statistically highly significant (P<0.0001), thereby indicating that GA correlated well with both GF and GV. Similar values between these 2 different types of correlation coefficient not only imply insignificant difference in the measurement characteristics between the groups but also reflect that no significant error was introduced in our experiment, thereby satisfying the pre-requisite of the simple linear regression analysis usually performed in glucose measurement [14, 16] as per the FDA recommendations for approval [19] .
3) Results of Passing-Bablok analysis
The Passing-Bablok analysis results are plotted in Fig.   3 with the regression lines showing the 95% confidence region (in between the dotted lines), and also with the internationally accepted limit lines (slope=unity±20%) [22, 23] . Since there were no significant intergroup differences with regard to the results of simple regression and intraclass correlation analyses, the data were pooled into GA-GF or GA-GV data sets. The slope of the GA-GF relationship (Fig. 3A ) was 1.04-1.14; therefore, the 95% confidence region was located inside the limit region (<±20%).
Similarly, the slope of GA-GV relationship was 1.08-1.20, thereby resulting in most of the 95% confidence region falling inside the limit region. Some outliers in the limit region in the hypoglycemic range can be attributed to nonideal constant values of -2.97~5.39 mg/dL and -16.57-3.00 mg/dL in the GA-GF and GA-GV relationships, respectively, both of which were much lower than the clinically acceptable limits [24] .
When the analysis was performed separately for each group, the slope parameter of the normal group was 1.30, which was higher than the acceptable value of 1.20 (Table   3 ). This can be attributed to the large number of data in the normal group falling within a narrow glucose range, which can result in a statistically erroneous slope value.
However, the 95% confidence region of the pooled data lies inside the acceptable region, as has been mentioned before; therefore, we think that the overall GA-GV relationship was clinically relevant.
DISCUSSION
Self-BGT using capillary blood sampled from the finger is a standard technique for the management of diabetes.
However, it induces pain and may force the patient to avoid the test, thereby leading to a failure in maintaining the appropriate glucose levels. Therefore, the pain experienced during sampling is considered to be a significant problem, minimize pain, and perhaps be a practical solution to this problem [14, 15] . While blood sampling from the forearm induces significantly less pain than that from the finger, only a small amount of blood, usually less than a few microliters, can be obtained due to the low degree of capillary distribution in the forearm. This small volume of blood is not sufficient for traditional glucometers. Fortunately, modern high-end but inexpensive glucometers, such as the one used in this study, can provide accurate glucose measurements within 5 sec by using less than 1 mL of blood.
Therefore, to minimize the pain during glucose self-testing, blood sampling from the forearm is a feasible and practical option.
The difference between the whole-blood glucose levels obtained by capillary blood sampling from the forearm and from the finger was reported to be statistically insignificant, but that assessment was performed in a limited number of subjects [16] . However, clinical practice usually requires additional validation in a sufficiently large subject population as well as over a wide range of glucose concentrations, and these requirements served as the motivations for the present study. We performed BGT at the forearm and at the finger almost simultaneously, and followed the procedures with BGT at the vein within an hour in more than 500 subjects, which can be considered a sufficiently large population. Since most study subjects had only visited the hospital for regular health check-ups, approximately 80% of them were normal and free of chronic diseases. To overcome this concern, we recruited 25 diabetic patients in the study. Since the experimental procedure was identical for all subjects, all data were pooled and then divided into the normal and the patient groups before analysis. We consider that the study population was appropriate to satisfy the objectives of this study for the following reasons: First, when comparing 2 different techniques, the most important pre-requisite is the measurement range, and the glucose concentration in our study ranged up to 350 mg/dL, which was approximately 4 times the normal fasting glucose level and was probably wide enough for most applications. Secondly, there is no reason to believe that the technique abruptly fails beyond this range, since the principle for the measurement of glucose, more specifically amperometry with enzyme process, has long been established both in vitro and in vivo. Thirdly, the present study population included many obese (57%) and aged (>60 yr) subjects (Table 1) who may be considered to have a potential risk of diabetes. In fact, 23% of the subjects had diabetes and/or hypertension.
Although our study population was appropriate, the normal group was much larger (494 subjects) than the patient (61) group; therefore, data analysis was performed separately on each group. FDA requires the performance of a simple linear regression analysis between the tested and the reference measurement techniques, and an additional analysis on the error grid is also recommended [19] . The reference technique (or the independent variable) must be a standard technique, which should be BGT by finger sampling or BGT with venous serum according to the recommendations of WHO [18] . Therefore, we chose the simple linear regression analysis as the first statistical method for the forearm BGT evaluation.
Since self-BGT is usually performed at home using a portable glucometer, GA-GF comparison is of major interest. Fig. 1 clearly shows that the regression lines fell very close to the identity line for both the normal and the patient groups, with a slight deviation of the slope and the constant from the ideal values of unity and zero, respectively. When comparing GA-GF data between the normal (Fig. 1A ) and the patient (Fig. 1B) groups, the normal group showed a relatively narrower GF range with a larger GA variance, probably because of a much larger sample size of subjects. Accordingly, the correlation coefficient of the normal group was somewhat lower than that of the patient group and showed slightly different slope and constant values from the theoretically ideal values of unity and zero, respectively. When compared by a paired t test, GA was significantly different from GF, but this difference was within the clinically acceptable bias. The linear relationship (or the regression lines) cannot exactly coincide with the identity line; thus, we think that the paired comparison is not an appropriate statistical test when the data are distributed over a wide range, such as those in our study. Instead, in such cases, the correlation analysis better describes the degree of agreement between the 2 measuring techniques. Nevertheless, the mean differences were <10 mg/dL, which corresponded to a mean relative error of <12% that was well below the international limit of 20% [22, 23] . Moreover, the fact that the regression lines between the normal and the patient groups were very much close to each other with statistically significant correlation coefficients shows that the forearm BGT provides values that are similar to the standard fingertip BGT with practically acceptable errors.
Although the essential goal of our study was to compare forearm BGT with the finger BGT in terms of pain reduction during glucose self-testing, we also measured the glucose concentration in venous serum to strengthen our experimental outcome. GA was measured immediately after GF, after which the subject moved to the Clinical Laboratory for venous blood sampling, which led to a time lag of 30-60 min between the GA and GV measurement.
Although GA and GV were measured with a 30-60 min time difference, we proceeded to perform GA-GV comparison under the assumption that the glucose level would not change significantly in overnight-fasted subjects (subjects who had fasted since the last supper of the previous day before visiting the hospital next morning). We think that this assumption is physiologically reasonable, and GA-GV data were also well-correlated as described in the following section.
Comparison of GA with GV, a standard measurement performed in hospitals, showed that both values were only slightly different, i.e., the mean differences were <±10 mg/dL ( Table 2 ). The GA-GV plots for the 2 groups showed a similar degree of scattering around the regression line of the GA-GF relationship ( Fig. 1, 2) . Although the linear relationship was similar to the GA-GF relationship, the slope values of both the normal and the patient groups revealed small but inherent differences in the GA-GV nature.
In Table 3 , the slope values of GA-GV relationships are lower than those of GA-GF relationships in both groups by the same magnitude (0.04-0.05), with comparable levels of the constant. Therefore, GA was measured consistently lower than G V by approximately 5%. Glucose in the whole blood is known to be lower than that in the plasma by 10-15% [18, 27] , and the commercially available glucometers for self-testing also show a similar tendency with the hematocrit [28] , a finding that is consistent with our results.
The industrial process of calibrating glucometers usually includes this hematocrit compensation procedure, which seemed to have been not completed in the glucometer used in this study, leading to 5% difference in GA-GV comparison. Furthermore, the time lag between GA and GV could also have affected this difference. However, the goodnessof-fit in regression analysis was satisfactory, similar to GA-GF relationship with the mean relative error of <±10% (Table 2) . Thus, GA could provide high-quality glucose measurements similar to those provided by the automated chemical analyzer in the Clinical Laboratory, with slight adjustments as required.
Although the above simple linear regression analysis is recommended by FDA [19] , since GF and GV are considered as standard measurement variables recommended by WHO [18] , the reference variables (GF and GV) may be assumed to be free of measurement error, an assumption that is not feasible under every practical situation. For further validation of our experimental results, we introduced the intraclass correlation coefficient [20] with a view that the forearm BGT and the finger (or the vein) BGT measure the same single variable (blood glucose) with no differences in technical properties. In such cases, the intraclass correlation analysis evaluates different types of correlation coefficients and shows the extent to which the 2 compared data sets agree with each other. As demonstrated in Table 3 , the intraclass correlation coefficient values showed a tendency similar to the Pearson correlation coefficients except that the values were slightly lower.
Therefore, we think that forearm BGT provides glucose measurements similar to those obtained from standard techniques widely applied at home as well as in hospitals.
Although both Pearson and intraclass correlation coefficients showed a good agreement of GA with GF or GV in the normal and the patient groups, this finding does not necessarily prove that the forearm BGT is clinically accept-able. This is because the variance of G A could be large enough to exceed the allowable limit in any particular range. A new measurement technique, in general, should demonstrate that data measured over a full range resides in the acceptable region. One method to assess this property of the data is to evaluate the 95% confidence interval (or region) and test whether it is within the acceptable range. Therefore, we performed the Passing-Bablok regression analysis on both GA-GF and GA-GV data [21] .
The normal and the patient group data were pooled because, firstly, both groups did not differ in the simple regression and the intraclass correlation analyses described above, and secondly, this regression technique does not require any a priori assumptions such as uniform distribution. As shown in Fig. 3 , the 95% confidence region (in between the dotted lines) was within the acceptable limit region (in between the solid lines with slope values of 0.8 and 1.2) [22, 23] . Therefore, forearm BGT can be considered to maintain a satisfactory accuracy over the entire range of blood glucose concentrations. However, a closer look at Fig. 3 shows us that the 95% confidence regions occupied an area above the identity line, which may indicate that GA was consistently higher than GF or GV. This may be true in regions where many data points are available (GF or GV ≤200 mg/dL), but this assumption does not hold true in the higher glucose region (GF or GV >200 mg/dL), where more data points were outside the 95% confidence region. In other words, even the Passing-Bablok regression analysis technique is affected to some degree in the presence of a sufficiently large degree of imbalance in data distribution, thereby indicating the inability of this method to accurately reveal the complete characteristics of our data. This was because our experiment included more normal subjects than diabetic patients. In other words, no single statistical analysis method can satisfactorily describe the highly non-uniform feature of the whole data set. Nevertheless, the fact that the 95% confidence regions are within the acceptable region implies that forearm BGT can be introduced into clinical practice with some cautions when necessary.
We think that the 3 kinds of statistical methods applied ticularly in hypoglycemia detection [30] . However, they mentioned that GA showed similar values to GF in the fasting state. Therefore, the time delay between GA and GF did not play a role in our fasting subjects; thus, we concluded that GA is a valid technique to monitor blood glucose, at least in the fasting state or ' ' for routine self-monitoring before meals' ' as suggested by a previous study [31] .
The ~35-min time delay between GA and GF under rapidly changing glucose concentrations observed by Jungheim and Koschinsky [29] may have been caused by the higher capillary circulation on the fingertip, which is 5-20 times higher than that at the forearm [32] [33] [34] , thereby leading to a slower glucose dynamics. On the other hand, McGarraugh [35] compared GA and GF with and without rubbing the forearm, and found that when the forearm was rubbed, the comparison yielded a nearly ideal correlation between GA and GF in the rapidly changing hyperglycemia region.
They noted a few shortcomings in the experimental protocol of Jungheim and Koschinsky [29] , e.g., they did not rub the test site; moreover, their protocol, which involved a glucose tolerance test followed by intravenous insulin administration, created physiological extremes. We particularly recommend caution in the detection of hypoglycemia, which is a frequent event in the diabetic patient' s routine self-testing regimen. We rubbed the forearm for 5 sec before blood sampling, similar to McGarraugh' s experimental protocol [35] ; thus, the time delay factor should have been minimized. Further, it should be noted that our comparison between GA and GF was only intended to measure glucose in the steady state, such as under fasting conditions, and hence, our results can be considered valid from this viewpoint.
After carefully reviewing our measurement data in both the normal and the patient groups, we found that GA was consistently higher than GF by a small margin (Fig. 1) , which is perhaps related to the slower dynamics at the forearm. Although the subjects were considered as being under steady state fasting conditions, the glucose levels might have been very slowly decreasing since the last meal;
in such a scenario, slightly higher GA could be observed.
In addition, rubbing the forearm to enhance local circulation may also have been performed for different dura- To further pursue the clinical applicability with a more reasonable approach, an evaluation tool called error grid analysis, different from statistical analysis, was introduced [24] . Correlation coefficients describe the linear relationship between 2 sets of data, as in this study. However, the correlation coefficients that evaluate the entire range of blood glucose values may misinterpret the true relationship between subsets of data, as explained in the report by Pohl et al. [36] . Error grid analysis is an efficient method that describes the accuracy over the entire range of blood glucose values and evaluates the clinical significance of the accuracy of a particular system. This analysis has been successfully applied in some studies [37, 38] . In this analysis, the test-reference (or GA-GF in The present study compared blood glucose measurements using samples taken from the forearm, samples obtained using standard finger skin puncture, and venous serum.
Capillary blood sampling technique used on the forearm can minimize pain and enables glucose measurements as accurate as those obtained by the standard blood sampling techniques used for the finger or the vein and performed under fasting conditions. Therefore, capillary blood sampling technique from an alternative site, such as the forearm, could be introduced in clinical practice, particularly in self-BGT before meals, for the successful management of diabetes.
